Literature DB >> 23076213

uPAR: a modulator of VEGF-induced angiogenesis.

Pavel Uhrin1, Johannes M Breuss.   

Abstract

Vascular endothelial growth factor (VEGF)-initiated angiogenesis requires both coordinated proteolytic degradation of extracellular matrix provided by the urokinase plasminogen activator/urokinase receptor (uPA/uPAR) system and regulation of cell-migration provided by integrin-matrix interaction. Previously we have shown that stimulation of pericellular proteolysis induced by VEGF occurs via the VEGF receptor-2 leading to redistribution of uPAR to focal adhesions at the leading edge of endothelial cells. In our recent work published in Cardiovascular Research, we investigated the mechanisms underlying the uPAR-dependent modulation of VEGF-induced endothelial migration. By applying a micropatterning technique we described that VEGF stimulation results in complex formation between uPAR and α 5β 1-integrin on the cell surface. The subsequent internalization of this complex, important for receptor redistribution, was demonstrated by flow-cytometry and immunohistochemistry. Targeting of the interaction site between uPAR and α 5β 1 impairs receptor internalization and leads to the inhibition of endothelial cell migration in vitro and in an angiogenesis model in vivo. This proof-of-principle that the interface of uPAR and α 5β 1-integrin may represent a promising site to therapeutically target tumor angiogenesis raises hope for the development of an anti-angiogenic approach that is limited to only the mobilizing effect of VEGF to endothelial cells, and does not interfere with the inarguably positive effect of VEGF as survival factor.

Entities:  

Year:  2012        PMID: 23076213      PMCID: PMC3544781          DOI: 10.4161/cam.22124

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  19 in total

1.  Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells.

Authors:  Ying Wei; Chi-Hui Tang; Young Kim; Liliane Robillard; Feng Zhang; Matthias C Kugler; Harold A Chapman
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

2.  Identification of a novel anti-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the beta 1 subunit.

Authors:  A P Mould; A N Garratt; J A Askari; S K Akiyama; M J Humphries
Journal:  FEBS Lett       Date:  1995-04-17       Impact factor: 4.124

3.  Identification of the urokinase receptor as an adhesion receptor for vitronectin.

Authors:  Y Wei; D A Waltz; N Rao; R J Drummond; S Rosenberg; H A Chapman
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

4.  An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.

Authors:  Roberta Mazzieri; Silvia D'Alessio; Richard Kamgang Kenmoe; Liliana Ossowski; Francesco Blasi
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

5.  A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth.

Authors:  Pratima Chaurasia; Julio A Aguirre-Ghiso; Olin D Liang; Henrik Gardsvoll; Michael Ploug; Liliana Ossowski
Journal:  J Biol Chem       Date:  2006-03-17       Impact factor: 5.157

6.  Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells.

Authors:  Gerald W Prager; Johannes M Breuss; Stefan Steurer; Judit Mihaly; Bernd R Binder
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

7.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.

Authors:  J D Vassalli; D Baccino; D Belin
Journal:  J Cell Biol       Date:  1985-01       Impact factor: 10.539

8.  Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.

Authors:  J A Aguirre Ghiso; K Kovalski; L Ossowski
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

9.  Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.

Authors:  R W Stephens; J Pöllänen; H Tapiovaara; K C Leung; P S Sim; E M Salonen; E Rønne; N Behrendt; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

10.  Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.

Authors:  J Bohuslav; V Horejsí; C Hansmann; J Stöckl; U H Weidle; O Majdic; I Bartke; W Knapp; H Stockinger
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.

Authors:  Anna Laurenzana; Gabriella Fibbi; Anastasia Chillà; Giancarlo Margheri; Tommaso Del Rosso; Elisabetta Rovida; Mario Del Rosso; Francesca Margheri
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

2.  Skin substitutes are more potent than dermal or epidermal substitutes in stimulating endothelial cell sprouting.

Authors:  Hanneke N Monsuur; Ester M Weijers; Susan Gibbs; Lenie J van den Broek
Journal:  BMC Biomed Eng       Date:  2019-07-17

3.  A novel in vivo model of puncture-induced iris neovascularization.

Authors:  Ophélie Beaujean; Filippo Locri; Monica Aronsson; Anders Kvanta; Helder André
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

4.  Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.

Authors:  Hai Li; Chen Chen
Journal:  Integr Cancer Ther       Date:  2017-03-09       Impact factor: 3.279

Review 5.  The Different Facades of Retinal and Choroidal Endothelial Cells in Response to Hypoxia.

Authors:  Effat Alizadeh; Parviz Mammadzada; Helder André
Journal:  Int J Mol Sci       Date:  2018-12-03       Impact factor: 5.923

Review 6.  The uPAR System as a Potential Therapeutic Target in the Diseased Eye.

Authors:  Maurizio Cammalleri; Massimo Dal Monte; Vincenzo Pavone; Mario De Rosa; Dario Rusciano; Paola Bagnoli
Journal:  Cells       Date:  2019-08-18       Impact factor: 6.600

Review 7.  The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.

Authors:  Asmaa Anwar Ismail; Baraah Tariq Shaker; Khalid Bajou
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 8.  The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.

Authors:  Yosuke Kanno
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

9.  Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy.

Authors:  Cornelia Schuster; Lars A Akslen; Tomasz Stokowy; Oddbjørn Straume
Journal:  J Pathol Clin Res       Date:  2018-11-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.